Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $257.33 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $72.34 | 4 | $0 (2018) |
| GlaxoSmithKline, LLC. | $49.66 | 3 | $0 (2021) |
| Novo Nordisk Inc | $34.36 | 2 | $0 (2017) |
| Stryker Corporation | $30.99 | 1 | $0 (2017) |
| Nevro Corp. | $30.31 | 1 | $0 (2017) |
| Celgene Corporation | $24.99 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $14.68 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $14.45 | 1 | GlaxoSmithKline, LLC. ($14.45) |
| 2019 | $17.09 | 1 | GlaxoSmithKline, LLC. ($17.09) |
| 2018 | $35.84 | 2 | GlaxoSmithKline, LLC. ($18.12) |
| 2017 | $189.95 | 9 | PFIZER INC. ($54.62) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/11/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: VACCINES | ||||||
| 03/29/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: VACCINES | ||||||
| 11/14/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: VACCINES | ||||||
| 03/12/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/14/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/02/2017 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/21/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Respiratory | ||||||
| 08/11/2017 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 07/13/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Diabetes | ||||||
| 07/13/2017 | PFIZER INC. | LYRICA (Drug), EMBEDA | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/15/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Diabetes | ||||||
| 03/02/2017 | Stryker Corporation | IVS - MultiGen RF (Device) | Food and Beverage | Cash or cash equivalent | $30.99 | General |
| Category: Interventional Spine | ||||||
| 01/31/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $24.99 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 3,691 | 7,051 | $1.4M | $594,954 |
| 2022 | 12 | 2,901 | 6,210 | $967,443 | $482,903 |
| 2021 | 9 | 1,642 | 3,498 | $556,410 | $278,399 |
| 2020 | 9 | 738 | 1,501 | $388,629 | $130,014 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 992 | 2,662 | $396,638 | $171,848 | 43.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 618 | 632 | $174,887 | $72,704 | 41.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 289 | 708 | $139,476 | $65,617 | 47.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 324 | 334 | $118,236 | $52,398 | 44.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 239 | 726 | $122,330 | $49,189 | 40.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 331 | 670 | $99,845 | $43,206 | 43.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 199 | 353 | $89,278 | $35,911 | 40.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 166 | 364 | $71,660 | $33,736 | 47.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 198 | 211 | $58,697 | $23,503 | 40.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 138 | 145 | $53,909 | $21,563 | 40.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 79 | 80 | $19,724 | $7,938 | 40.2% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 35 | 35 | $12,390 | $5,504 | 44.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 39 | 62 | $10,153 | $4,078 | 40.2% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 12 | 37 | $10,138 | $4,072 | 40.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 32 | 32 | $8,864 | $3,685 | 41.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 653 | 2,231 | $261,027 | $128,350 | 49.2% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 281 | 779 | $116,850 | $62,813 | 53.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 259 | 932 | $113,704 | $55,902 | 49.2% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 341 | 349 | $96,673 | $48,761 | 50.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 278 | 620 | $97,340 | $47,426 | 48.7% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 393 | 401 | $86,215 | $43,098 | 50.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 206 | 376 | $65,800 | $32,533 | 49.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 134 | 143 | $48,620 | $23,854 | 49.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 173 | 181 | $41,087 | $20,442 | 49.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 109 | 116 | $21,112 | $10,405 | 49.3% |
About Dr. David Taftian, D.O
Dr. David Taftian, D.O is a Physical Medicine & Rehabilitation healthcare provider based in Reseda, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2011. The National Provider Identifier (NPI) number assigned to this provider is 1376823153.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Taftian, D.O has received a total of $257.33 in payments from pharmaceutical and medical device companies, with $14.45 received in 2021. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($257.33).
As a Medicare-enrolled provider, Taftian has provided services to 8,972 Medicare beneficiaries, totaling 18,260 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Physical Medicine & Rehabilitation
- Location Reseda, CA
- Active Since 08/24/2011
- Last Updated 06/27/2024
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376823153
Products in Payments
- LYRICA (Drug) $54.67
- SHINGRIX (Biological) $49.66
- Victoza (Drug) $34.36
- IVS - MultiGen RF (Device) $30.99
- Senza Spinal Cord Stimulation System (Device) $30.31
- CHANTIX (Drug) $17.67
- SYMBICORT (Drug) $14.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Reseda
Nouriel Niamehr, Do, DO
Physical Medicine & Rehabilitation — Payments: $6,567
Habib Fatolomi, M.d, M.D
Physical Medicine & Rehabilitation
Nanet Tolentino, Pt, PT
Physical Medicine & Rehabilitation
Katie Kavinski, Dpt, DPT
Physical Medicine & Rehabilitation